WTAP and m 6 A-modified circRNAs modulation during stress response in acute myeloid leukemia progenitor cells

• Published in: Cellular and molecular life sciences : CMLS 2024-06, Vol.81 (1), p.276
• Main Authors: Iaiza, Alessia, Mazzanti, Gilla, Goeman, Frauke, Cesaro, Bianca, Cortile, Clelia, Corleone, Giacomo, Tito, Claudia, Liccardo, Francesca, De Angelis, Luciana, Petrozza, Vincenzo, Masciarelli, Silvia, Blandino, Giovanni, Fanciulli, Maurizio, Fatica, Alessandro, Fontemaggi, Giulia, Fazi, Francesco
• Format: Article
• Language: English
• Subjects: Adenosine - analogs & derivatives; Adenosine - metabolism; Adenosine - pharmacology; Bortezomib - pharmacology; Cell Cycle Proteins - genetics; Cell Cycle Proteins - metabolism; Cell Line, Tumor; Heme Oxygenase-1 - genetics; Heme Oxygenase-1 - metabolism; Humans; Intracellular Signaling Peptides and Proteins; Leukemia, Myeloid, Acute - drug therapy; Leukemia, Myeloid, Acute - genetics; Leukemia, Myeloid, Acute - metabolism; Leukemia, Myeloid, Acute - pathology; Neoplastic Stem Cells - drug effects; Neoplastic Stem Cells - metabolism; Neoplastic Stem Cells - pathology; Oxidative Stress - drug effects; Protein Serine-Threonine Kinases; Reactive Oxygen Species - metabolism; RNA Splicing Factors - genetics; RNA Splicing Factors - metabolism; RNA, Circular - genetics; RNA, Circular - metabolism
• ISSN: 1420-9071
• DOI: 10.1007/s00018-024-05299-9

N -methyladenosine (m A) is one of the most prevalent and conserved RNA modifications. It controls several biological processes, including the biogenesis and function of circular RNAs (circRNAs), which are a class of covalently closed-single stranded RNAs. Several studies have revealed that proteotoxic stress response induction could be a relevant anticancer therapy in Acute Myeloid Leukemia (AML). Furthermore, a strong molecular interaction between the m A mRNA modification factors and the suppression of the proteotoxic stress response has emerged. Since the proteasome inhibition leading to the imbalance in protein homeostasis is strictly linked to the stress response induction, we investigated the role of Bortezomib (Btz) on m A regulation and in particular its impact on the modulation of m A-modified circRNAs expression. Here, we show that treating AML cells with Btz downregulated the expression of the m A regulator WTAP at translational level, mainly because of increased oxidative stress. Indeed, Btz treatment promoted oxidative stress, with ROS generation and HMOX-1 activation and administration of the reducing agent N-acetylcysteine restored WTAP expression. Additionally, we identified m A-modified circRNAs modulated by Btz treatment, including circHIPK3, which is implicated in protein folding and oxidative stress regulation. These results highlight the intricate molecular networks involved in oxidative and ER stress induction in AML cells following proteotoxic stress response, laying the groundwork for future therapeutic strategies targeting these pathways.